ArticleJournal of inflammation research2025
Danshensu Ethyl Ester Alleviates LPS-Induced Acute Lung Injury by Targeting the NLRP3 Inflammasome.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Danshensu Ethyl Ester Induces Ferroptosis Through Targeted Inhibition of SLC7A11 Transport Function in NSCLC.Thoracic cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate whether Danshensu ethyl ester (DEE) can attenuate acute lung injury (ALI) and explore the detailed mechanism. Methods: The ALI model was induced in mice using LPS. The effects of DEE on lung wet-to-dry weight ratio (W/D), bronchoalveolar lavage fluid (BALF) protein levels, and neutrophil infiltration (neutrophils) were assessed. In addition, molecular docking and molecular dynamics simulations were also carried out to determine the binding situation between DEE and NLRP3. We evaluated in both in vivo and in vitro models the expression of NLRP3-related proteins as well as the release of cytokines. The generation of reactive oxygen species (ROS) and the formation of ASC fluorescent specks in cells were also observed. Results: The results demonstrated that DEE significantly alleviated pulmonary edema and lung injury of mice. Molecular docking and simulations revealed that DEE directly targets and tightly binds to the NLRP3 protein. Furthermore, both in vivo and in vitro experiments showed that DEE suppressed activation of the NF-κB signaling pathway induced by LPS, and decreased the expression of NLRP3, ASC, and cleaved caspase-1, inhibiting the release of cytokines such as IL-1β, IL-6, and TNF-α. Additionally, DEE suppressed ROS generation and ASC specks formation, thereby inhibiting the assembly and activation of the NLRP3 inflammasome. Conclusion: DEE exerts an inhibitory influence on the LPS-induced inflammatory response by suppressing the activation of the NLRP3 inflammasome. This study provides the potential application of DEE in NLRP3-driven ALI therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.